AAAAAA
Results:
1-7
|
Results: 7
Authors:
O'Harte, FPM
Mooney, MH
Kelly, CMN
McKillop, AM
Flatt, PR
Citation: Fpm. O'Harte et al., Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice, REGUL PEPT, 96(3), 2001, pp. 95-104
Authors:
McKillop, AM
Mooney, MH
Harriott, P
Flatt, PR
O'Harte, FPM
Citation: Am. Mckillop et al., Evaluation of glycated insulin in diabetic animals using immunocytochemistry and radioimmunoassay, BIOC BIOP R, 286(3), 2001, pp. 524-528
Authors:
O'Harte, FPM
Mooney, MH
Lawlor, A
Flatt, PR
Citation: Fpm. O'Harte et al., N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo, BBA-GEN SUB, 1474(1), 2000, pp. 13-22
Authors:
McKillop, AM
McCluskey, JT
Boyd, AC
Mooney, MH
Flatt, PR
O'Harte, FPM
Citation: Am. Mckillop et al., Production and characterization of specific antibodies for evaluation of glycated insulin in plasma and biological tissues, J ENDOCR, 167(1), 2000, pp. 153-163
Authors:
O'Harte, FPM
Mooney, MH
Kelly, CMN
Flatt, PR
Citation: Fpm. O'Harte et al., Improved glycaemic control in obese diabetic ob/ob mice using N-terminallymodified gastric inhibitory polypeptide, J ENDOCR, 165(3), 2000, pp. 639-648
Authors:
Abdel-Wahab, YHA
O'Harte, FPM
Mooney, MH
Conlon, JM
Flatt, PR
Citation: Yha. Abdel-wahab et al., N-terminal glycation of cholecystokinin-8 abolishes its insulinotropic action on clonal pancreatic B-cells, BBA-MOL CEL, 1452(1), 1999, pp. 60-67
Authors:
O'Harte, FPM
Mooney, MH
Flatt, PR
Citation: Fpm. O'Harte et al., NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity, DIABETES, 48(4), 1999, pp. 758-765
Risultati:
1-7
|